Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Makarand Jawadekar Insider Profile
4 Followers
Makarand Jawadekar, Senior Officer at PreveCeutical Medical, holds 500.50K shares in PreveCeutical Medical (Ticker: PRVCF).
Makarand Jawadekar has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Makarand Jawadekar's holdings
Insider Roles
Senior Officer
Roles that Makarand Jawadekar holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Makarand Jawadekar
Makarand Jawadekar's Trading History
List of latest transactions for each holding click on a transaction to see Makarand Jawadekar's performance on stock
You May Also Like
Makarand Jawadekar insider profile FAQ
What is the percentage of profitable transactions made by Makarand Jawadekar?
The percentage of profitable transactions made by Makarand Jawadekar is ―.
What is the average return per transaction made by Makarand Jawadekar?
The average return per transaction made by Makarand Jawadekar is ―.
What stocks does Makarand Jawadekar hold?
Makarand Jawadekar holds: PRVCF stocks.
What was Makarand Jawadekar’s latest transaction?
Makarand Jawadekar latest transaction was an Uninformative Buy of $250.25K.
What was Makarand Jawadekar's most profitable transaction?
Makarand Jawadekar’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Makarand Jawadekar's role in PreveCeutical Medical?
Makarand Jawadekar's role in PreveCeutical Medical is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.